Matinas BioPharma
MTNB
MTNB
48 hedge funds and large institutions have $6.15M invested in Matinas BioPharma in 2024 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 6 increasing their positions, 8 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
25% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 8
Holders
48
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$1.68M | |
| 2 | +$299K | |
| 3 | +$299K | |
| 4 |
Wells Fargo
San Francisco,
California
|
+$39.3K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$24.7K |
Top Sellers
| 1 | -$440K | |
| 2 | -$18.8K | |
| 3 | -$12.8K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$12.2K |
| 5 |
TW
Trajan Wealth
Scottsdale,
Arizona
|
-$1.38K |